Ariadne Kristin DeSimone, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 5 | 2023 | 2106 | 0.820 |
Why?
|
| Diagnostic Errors | 2 | 2024 | 1278 | 0.610 |
Why?
|
| Preceptorship | 1 | 2017 | 57 | 0.560 |
Why?
|
| Fluoroscopy | 1 | 2017 | 948 | 0.420 |
Why?
|
| Radiology, Interventional | 1 | 2017 | 483 | 0.420 |
Why?
|
| Internship and Residency | 4 | 2022 | 5947 | 0.420 |
Why?
|
| Schools, Medical | 1 | 2017 | 883 | 0.360 |
Why?
|
| Teaching | 1 | 2017 | 1172 | 0.330 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 3236 | 0.320 |
Why?
|
| Quality Improvement | 1 | 2024 | 3854 | 0.300 |
Why?
|
| Curriculum | 2 | 2022 | 3786 | 0.300 |
Why?
|
| Students, Medical | 2 | 2018 | 1965 | 0.280 |
Why?
|
| Education, Medical | 1 | 2017 | 1746 | 0.250 |
Why?
|
| Radiography, Thoracic | 2 | 2023 | 1320 | 0.220 |
Why?
|
| Bronchi | 1 | 2024 | 847 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 13491 | 0.160 |
Why?
|
| Medical Errors | 2 | 2018 | 1260 | 0.160 |
Why?
|
| Medical Order Entry Systems | 1 | 2024 | 523 | 0.150 |
Why?
|
| Patient Identification Systems | 1 | 2018 | 75 | 0.150 |
Why?
|
| Georgia | 1 | 2017 | 186 | 0.140 |
Why?
|
| Portraits as Topic | 1 | 2016 | 33 | 0.130 |
Why?
|
| Communication | 2 | 2023 | 3904 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1515 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2024 | 1161 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 1065 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2017 | 570 | 0.120 |
Why?
|
| Photography | 1 | 2018 | 536 | 0.120 |
Why?
|
| Fixation, Ocular | 1 | 2016 | 243 | 0.120 |
Why?
|
| Radiography | 1 | 2023 | 6975 | 0.100 |
Why?
|
| Eligibility Determination | 1 | 2015 | 421 | 0.100 |
Why?
|
| Medical Records | 1 | 2017 | 1409 | 0.100 |
Why?
|
| Program Development | 1 | 2017 | 1298 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81659 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 1144 | 0.080 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 969 | 0.080 |
Why?
|
| Visual Perception | 1 | 2016 | 1392 | 0.070 |
Why?
|
| Motivation | 1 | 2017 | 2021 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2420 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2017 | 4859 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 3530 | 0.060 |
Why?
|
| Humans | 11 | 2024 | 767040 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20741 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 54886 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26325 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 40154 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2015 | 165 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 2276 | 0.020 |
Why?
|
| Male | 4 | 2024 | 364203 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8736 | 0.020 |
Why?
|
| Female | 4 | 2024 | 396660 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2015 | 1882 | 0.010 |
Why?
|
| United States | 2 | 2018 | 72971 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15851 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 223317 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 171319 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 223233 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 59980 | 0.000 |
Why?
|